Fundz

Respiro Diagnostics has secured £1M in pre-seed funding led by Zinc Venture Capital to advance its breath-based diagnostics for lung diseases.

PRIVATEJul 08, 2026

Amount Raised

£1 Million

Round Type

Pre-Seed

United KingdomBiotechnologyHealth CareMedical DeviceTherapeuticsHealth Diagnostics

Investors

SFC CapitalAmadeus Capital PartnersConception X Angel SyndicateKq LabsInnovate UKZinc Venture Capital

Description

Respiro Diagnostics, a UK-based startup, has raised £1 million in a pre-seed funding round. The funding will support clinical research and development of a non-invasive device for lung diagnostics. Led by Zinc Venture Capital, this round includes several notable investors. The company aims to provide early diagnosis through breath samples, potentially transforming lung disease diagnostics.

Who to call at Respiro Diagnostics, and when

A new round usually means Respiro Diagnostics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Respiro Diagnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Respiro Diagnostics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Respiro Diagnostics

Location

United Kingdom

About

Respiro Diagnostics is a UK-based startup focused on developing breath-based diagnostics for lung diseases. The company is creating a non-invasive liquid biopsy platform that uses exhaled breath to detect lung cancer and other respiratory diseases. Their technology combines a proprietary breath collection device with advanced laboratory methods to analyze biological material from breath samples. This approach aims to provide earlier diagnosis and enhance treatment decisions for lung-related health issues.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Respiro Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAlison Q., Co-Founder and CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Respiro Diagnostics's next move

See what Strategic adds

Respiro Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.